OrthogenRx
Doylestown
About OrthogenRx
OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices for the treatment of musculoskeletal conditions. The business model utilizes exclusive supply and license agreements for products presently on the market ex-US and seeks generic product approval in the U.S. potentially saving the healthcare system billions in cost. The strategy utilizes existing regulations for an abbreviated regulatory approval for generic devices, analogous to generic drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.5M
- Funding stage: M&A
- Last round: Seed (May 2017)
- Website: orthogenrx.com
- Phone: (215) 693-1066
Industries & Categories
Biotechnology, Commercial, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/orthogenrx-154780 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.